Back to top

Image: Bigstock

Has Bicycle Therapeutics PLC Sponsored (BCYC) Outpaced Other Medical Stocks This Year?

Read MoreHide Full Article

The Medical group has plenty of great stocks, but investors should always be looking for companies that are outperforming their peers. Has Bicycle Therapeutics PLC Sponsored (BCYC - Free Report) been one of those stocks this year? Let's take a closer look at the stock's year-to-date performance to find out.

Bicycle Therapeutics PLC Sponsored is a member of the Medical sector. This group includes 898 individual stocks and currently holds a Zacks Sector Rank of #1. The Zacks Sector Rank considers 16 different groups, measuring the average Zacks Rank of the individual stocks within the sector to gauge the strength of each group.

The Zacks Rank is a proven model that highlights a variety of stocks with the right characteristics to outperform the market over the next one to three months. The system emphasizes earnings estimate revisions and favors companies with improving earnings outlooks. BCYC is currently sporting a Zacks Rank of #2 (Buy).

Within the past quarter, the Zacks Consensus Estimate for BCYC's full-year earnings has moved 22.19% higher. This is a sign of improving analyst sentiment and a positive earnings outlook trend.

According to our latest data, BCYC has moved about 35.42% on a year-to-date basis. Meanwhile, the Medical sector has returned an average of -14.43% on a year-to-date basis. As we can see, Bicycle Therapeutics PLC Sponsored is performing better than its sector in the calendar year.

Looking more specifically, BCYC belongs to the Medical - Biomedical and Genetics industry, a group that includes 385 individual stocks and currently sits at #41 in the Zacks Industry Rank.

Going forward, investors interested in Medical stocks should continue to pay close attention to BCYC as it looks to continue its solid performance.

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Bicycle Therapeutics PLC Sponsored ADR (BCYC) - free report >>

Published in